The number of trains serving The London Cancer Hub’s local rail station, Belmont, is set to double thanks to £14m from the Government’s Levelling Up Fund.

Personalised cancer medicine start-up Curesponse has become the latest MedTech company to move in at the Innovation Gateway at The London Cancer Hub in Sutton, south London.

Precision medicine start-up enterprise Vesynta has become the first MedTech company to move into a sophisticated laboratory at south London’s newest incubator space, the Innovation Gateway at The London Cancer Hub in Sutton.